SCHEMBL9516441

SCHEMBL9516441

CCCCCCCCCCCOCc1ccc(C(=O)[O-])cc1OCCCCCCCCCCC.[Na+]

nearest known ligand 0.50

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
THRA known ✓ P10827 1/20 0.43
THRB known ✓ P10828 1/20 0.43
SMPD1 P17405 5/20 0.47
PLA2G2D Q9UNK4 1/20 0.46
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44
PTPN11 Q06124 1/20 0.43
CNR2 P34972 4/20 0.43
CNR1 P21554 3/20 0.43
TP53 P04637 1/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9513101 1.00 SMPD1 (0.47) SMPD1PLA2G2DALDH1A1HPGDPTPN11
SCHEMBL9515434 1.00 SMPD1 (0.47) SMPD1PLA2G2DALDH1A1HPGDPTPN11
SCHEMBL9513056 0.88 PLA2G2D (0.58) PLA2G2DALDH1A1HPGDPTPN11TP53
SCHEMBL9515491 0.88 PLA2G2D (0.58) PLA2G2DALDH1A1HPGDPTPN11TP53
SCHEMBL9514125 0.88 PLA2G2D (0.58) PLA2G2DALDH1A1HPGDPTPN11TP53
SCHEMBL9515443 0.87 PLA2G2D (0.57) SMPD1PLA2G2DALDH1A1HPGDPTPN11
SCHEMBL9513108 0.87 PLA2G2D (0.57) SMPD1PLA2G2DALDH1A1HPGDPTPN11
SCHEMBL9516447 0.87 PLA2G2D (0.57) SMPD1PLA2G2DALDH1A1HPGDPTPN11
SCHEMBL9513086 0.87 SMPD1 (0.49) SMPD1PLA2G2DALDH1A1HPGDPTPN11
SCHEMBL9516481 0.85 NPC1 (0.53) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0308977-B1 Anthracycline derivatives having inhibitory activity against reverse transcriptase of human immunodeficiency virus ZAIDAN HOJIN BISEIBUTSU (JP) 1993-12-08 EP disclosed
US-5003055-A Anthracycline derivatives having inhibitory activity against reverse transcriptase of human immunodeficiency virus ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) 1991-03-26 US disclosed
EP-0308977-A2 Anthracycline derivatives having inhibitory activity against reverse transcriptase of human immunodeficiency virus ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) 1989-03-29 EP disclosed